Selected
Case Studies

Transaction with North American VCs
#1. Provided a liquidity facility into a publicly traded, North American VC fund in return for an economic interest in 15 companies along with follow-on capital and investment management agreement • Included Ambit, which was acquired by Daiichi Sankyo for $410M and GeminX acquired by Cephalon for $525M #2. Completed a synthetic secondary of 8 private companies in a North American VC fund along with follow-on capital to support those companies through value milestones • Included Enobia Pharma which was acquired by Alexion for $1.1B

Transaction with Schroder UK Public Private Trust plc

Secondary transaction to acquire seven equity positions in healthcare companies

Transaction with GrowthWorks Canadian Fund

Secondary transaction to acquire fifteen equity positions in healthcare companies

Secondary Transactions with Corporate Venture Capital arms
Rosetta Capital has completed secondary transactions with Corporate Venture Capital arms of Top 10 Pharma companies to provide liquidity for strategic realignment.

Top 10 Pharma Corporate Venture Capital

Secondary transaction to acquire over 10 equity positions in healthcare companies

Secondary Transactions with Academic Institutions
Rosetta Capital has completed secondary transactions with academic institutions to acquire equity positions in healthcare portfolio companies

Karolinska Development

Secondary transaction to acquire thirteen equity positions in healthcare companies

Find out more

Our focus

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Faucibus sodales gravida vulputate nullam augue. Ut nam fermentum, ullamcorper nascetur ac tincidunt lacus, montes, libero. Ullamcorper amet mauris non.

Our people

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Faucibus sodales gravida vulputate nullam augue. Ut nam fermentum, ullamcorper nascetur ac tincidunt lacus, montes, libero. Ullamcorper amet mauris non sapien sed.